The House Energy and Commerce Committee last night approved a revised version of the Lower Prescription Drug Costs Now Act (H.R. 3) — legislation that would make a series of changes to the Medicare program in an effort to lower the price of prescription drugs. During the markup, which lasted nearly eight hours, the committee adopted only one amendment, which would increase the Medicare Part B reimbursement for biosimilars for five years.
 
The legislation would increase the number of single-source drugs from 25 to 35 that the Department of Health and Human Services would be required to negotiate directly with drug manufacturers. The bill, which was introduced last month, would, among other provisions, apply new inflationary rebates to Medicare Part B and Part D drugs that have had price increases above the rate of inflation since 2016; cap the Medicare Part D annual out-of-pocket limit at $2,000 and convert the current coverage gap into a benefit-wide responsibility; and realign the Medicare Part D catastrophic phase cost-sharing responsibilities.
 
The House Education and Labor Committee approved its version of the bill yesterday. The House Ways and Means Committee is expected to mark up the bill next week, and the full House of Representatives will likely consider the bill in the coming weeks.

Related News Articles

Headline
The House May 22 passed the fiscal year 2025 budget reconciliation bill, the One Big Beautiful Bill Act by a 215-214 vote. The legislation includes significant…
Headline
The Department of Health and Human Services May 20 announced it has identified specific pricing targets for pharmaceutical manufacturers to meet to satisfy…
Headline
As Congress weighs significant changes and cuts to Medicaid, the AHA today hosted a Capitol Hill briefing for congressional staff featuring hospital and health…
Headline
The House Budget Committee May 16 voted 21-16 against advancing the fiscal year 2025 budget reconciliation bill, with five Republicans joining all Democrats in…
Perspective
Public
Three key House committees — Energy and Commerce, Ways and Means, and Agriculture — after long debates and discussions this week advanced their portions of a…
Headline
The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation…